advancements in use of combination drugs in clinical trials: nivolumab, pembrolizumab, and more
Published 7 years ago • 120 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
1:28
early clinical trials of immunotherapy treatment combinations
-
1:42
novel triple combination therapies for melanoma
-
1:09
the future role of immunotherapy in head and neck cancers
-
1:19
developments in immunotherapy for lung cancer
-
3:34
recent developments in melanoma with brain metastases
-
10:42
what is new in melanoma?
-
10:27
immunotherapy for cancer treatment: new hope or more hype?
-
5:19
battling melanoma: brooke wilson shares her story
-
28:38
treatment of brain metastases | won kim, md | uclamdchat
-
3:54
the four phases of clinical trials | diversity in clinical trials | akf
-
2:03
melanoma immunotherapy updates in 2016: clinical trials, developments and new survival data
-
25:34
novel immunotherapies and combinations
-
3:30
asco's first-ever clinical trial: the tapur study
-
4:27
key updates in immunotherapies for melanoma
-
2:30
advancements in treating brain metastases in cancer
-
3:28
keynote-775 subgroup analysis in advanced endometrial cancer
-
2:48
clinical trials investigating the management of immune-related adverse events
-
24:19
clinical trials, what are they & how do you i participate?
-
1:04
the safety of nivolumab for advanced melanoma
-
9:31
new options for immunotherapy trials
-
1:48
influence of new immunotherapy checkpoint inhibitors in melanoma
-
2:10
combined treatment with braf and mek inhibitors in metastatic melanomas with braf mutations